Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13635| Title: | Pathophysiology of diabetic nephropathy. | Austin Authors: | Cooper, Mark E;Gilbert, Richard E;Epstein, M | Affiliation: | Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Heidelberg, Victoria, Australia | Issue Date: | 1-Dec-1998 | Publication information: | Metabolism: Clinical and Experimental; 47(12 Suppl 1): 3-6 | Abstract: | Diabetic nephropathy (DN) is now the commonest cause of end-stage renal failure in the Western world. Recent studies examining the pathogenesis of diabetic complications have focused on the complex interaction between genetic and hemodynamic mechanisms in addition to metabolic factors such as advanced glycation, protein kinase C (PKC) activation, and polyol production. The importance of the various components, particularly with regard to the progression of DN, is currently being explored with the assistance of targeted drug intervention studies. | Gov't Doc #: | 9867062 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/13635 | Journal: | Metabolism: clinical and experimental | URL: | https://pubmed.ncbi.nlm.nih.gov/9867062 | Type: | Journal Article | Subjects: | Diabetic Nephropathies.genetics.metabolism.physiopathology.therapy Glycosylation End Products, Advanced.metabolism Hemodynamics.physiology Humans Polymers.metabolism |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.